Up next
- Moderna Surges on Cancer Vaccine; Estee Lauder Rallies on Earnings | Stock Movers
- Target Raises Sales Outlook as Turnaround Gains Strength
- Target's Turnaround Is Finally Working: Telsey Analyst
- Merck, Moderna Stocks Soar After Melanoma Trial Success
- Lerner: Give Bull Market Benefit of the Doubt
- SK Hynix Announces $29 Billion Share Buyback Plan
